Subscribe to one of our feedsfont size
PrintEditor's Picks
Back « 1 2 3 4 5 6 7 ... » Next
- House Panel Criticizes F.D.A. Role in Drug Cases
The New York Times - Senior drug benefit gets "mixed picture" review
Reuters - Drug giant to buy Sirtris for $720m
The Boston Globe - State looks to get in on biotech ground floor
The Boston Herald - US watchdog critical of FDA foreign drug oversight
Reuters - Drug studies for hire
The San Jose Mercury News - U.S. Identifies Tainted Heparin in 11 Countries
The New York Times - Bird flu resurfaces in northeast India
Reuters - Researchers envision stem cell lab
San Diego Union Tribune - Fewer general surgeons in U.S.: researchers
Reuters - Cancer Drugs May Kill Neural Stem Cells, Causing `Chemo Brain'
Bloomberg - In Lean Times, Biotech Grains Are Less Taboo
The New York Times - States Crack Down On Online Gene Tests
Forbes - Benefit Managers Profit by Specialty Drug Rights
The New York Times - PETA's Latest Tactic: $1 Million for Fake Meat
The New York Times - Web guru targets malaria with social network site
Reuters - New technique could help safeguard cancer patients' fertility
The Guardian - Democrats propose country of origin rule for food, drugs
The Associated Press - Pentagon-funded research into regrowing limbs lost in war
AFP - A Jump in Doctor Visits and Deaths in Flu Season
The New York Times - Prozac might cure "lazy eye", scientists say
Reuters - Glaxo's Tykerb reduces breast cancer stem cells
Reuters - Warning on Storage of Health Records
The New York Times - Doctors say insurance company rankings of doctors are based on cost, not quality.
Newsweek - New Calculator Factors Chances for Very Premature Infants
The New York Times - Mid-life high cholesterol raises Alzheimer's risk
Reuters - An explanation for the increasing incidence of autism
The Economist - Panel's Bipartisan View: F.D.A. Is Underfinanced
The New York Times - Merck Wrote Drug Studies for Doctors
The New York Times - FDA plans to open China office in May
The Associated Press - French Bill Takes Chic Out of Being Too Thin
The New York Times - Big pharma aims to show the drugs still sell
Reuters - Citing Ethics, Some Doctors Are Rejecting Industry Pay
The New York Times - WellPoint developing drug safety monitoring system
Reuters - Testosterone predicts profits on trading floors
Reuters - Sperm and eggs from stem cells 'in 15 years'
The Times - Blood pressure drug reduces bone density in study
Reuters - Co-Payments Go Way Up for Drugs With High Prices
The New York Times - Novartis CEO says further buys are possible -paper
Reuters - Germany relaxes stem cell legislation
AFP - The Dangers in Pre-emption
The New York Times - In U.S., Few Alternatives To Testing On Animals
The Washington Post - Vaccine Safety Panel to Include the Public in Setting Priorities
The Associated Press - On the Retail Frontier, Another Shop in SoHo for the Person Who Has Everything
The New York Times - Inhaled insulin flops, but field may hold promise
Reuters - Big U.S. study links breast cancer to drinking
Reuters - Embryonic Stem Cells' Safety Weighed by FDA
Bloomberg - Lilly, Wyeth Vie for 18 Million Alzheimer's Patients
Bloomberg - Drug protects mice, monkeys from radiation damage
Reuters - Heart ills not to blame for women's poor sex life
Reuters - Amgen Develops Six Cancer Drugs as Anemia Sales
Bloomberg - Takeda to Buy Millennium Pharma for $8.8 Billion
Bloomberg - Pfizer warns of lung cancer link with inhaled insulin
AFP - Roche appeals preliminary anemia drug injunction
Reuters - Biotech chief shifts investment focus
Financial Times - In Shift to Digital, More Repeat Mammograms
The New York Times - French GMO bill passes lower house of parliament
Reuters - Study debunks heart attack-male baldness link
Reuters - Mumps found to have made alarming comeback in U.S.
Reuters - $1 per gallon biofuel touted
The Republican - Cancer drug trials 'being stopped too soon'
Daily Telegraph - FDA cites 62 reports of possible heparin deaths
Reuters - Icahn files suit to gain access to Biogen records
Reuters - Selling Stem Cells
Technology Review - Harnessing Biology, and Avoiding Oil, for Chemical Goods
The New York Times - World food shortages to stay, riots a risk: FAO
Reuters - FDA says Glaxo failed to report Avandia data
Reuters - Kinetic Concepts to Buy LifeCell for $1.7 Billion
Bloomberg - Stem-Cell Studies in People Examined by FDA on Safety
Bloomberg - A Disease That Allowed Torrents of Creativity
The New York Times - India converts failing vaccine plants to testing labs
in-Pharma Technologist - Drug errors hurt 1 in 15 hospitalized kids
MSNBC - Drug Makers Near Old Goal: A Legal Shield
The New York Times - Big pharma drive for UK industry
The Times - Army Is Worried by Rising Stress of Return Tours to Iraq
The New York Times - State bill could ease life science taxes
The Silicon Valley/San Jose Business Journal - Transplanted Brain Cells May Suffer From Parkinson's `Spread'
Bloomberg - JP Morgan bets on large biotechs to beat recession
Reuters - Gene Tests May Be More Confusing Than Illuminating
Bloomberg - Resistant microbe entering hospitals
Reuters - Scientists find host of antibiotic-eating germs
Reuters - State Senate panel OKs bill to label cloned foods
The San Francisco Chronicle - Schering plans $1B cutback as Vytorin, Zetia fall
The Star-Ledger - Lawyers Fight DNA Samples Gained on Sly
The New York Times - Report Claims Clinical Trials Miss Many Populations
HealthDay News - TV drug ads should list FDA hotline, lawmakers say
The Los Angeles Times - 60-Plus, Ripped, and Natural Competitors
The New York Times - China approves bird flu vaccine for humans
Reuters - Research debunks health value of guzzling water
Reuters - Court rejects Patent Office's new rules
Reuters - Reynolds Ads Say Tobacco Oversight Is Burden F.D.A. Doesn't Need
The New York Times - Study Is Setback for Some RNA-Based Drugs
The New York Times - Is Biotech's Health Improving?
Standard & Poors - Scientists create Britain's first hybrid embryos
The Independent - Researchers say gene could help dope cheats
Reuters - Accusations of Delays in Releasing Drug Results
The New York Times - Congress scrutinizes drug ads
Bloomberg - EU's ageing science workforce could damage future innovations
in-Pharma Technologist - Measure could cut biotech funding
Palm Beach Post - Doctors support universal health care: survey
Reuters
Back « 1 2 3 4 5 6 7 ... » Next
- Obesity contributes to global warming: study
Reuters - Heart risks high in childhood cancer survivors
Reuters - Study Links Rise in Mastectomies to M.R.I. Detection
The New York Times - Amgen's Denosumab Cuts Fractures in Cancer Patient
Bloomberg - Geron Stem Cell Trial Held Up by FDA; Shares Fall
Bloomberg - Cancer drug sales could hit $80 billion by 2011: IMS
Reuters - Dennis Quaid backs drugmaker liability suits
Reuters - Health ministers to debate drug patent dispute
Reuters - Medical Journal's Article Questions TV Ads for Stent
The New York Times - Serious Deficiencies in Nursing Homes Are Often Missed, Report Says
The New York Times